Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

99.29 

-1.67 -1.7%

as of Aug 23 '19

52 Week Range:

56.91 102.56


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors; and VCARE uterine manipulator for enhancing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 18.32
19.77
20.78
21.82
21.39
21.47
21.51
20.84
20.99
21.09
23.20
growth rate 7.9% 5.1% 5.0% -2.0% 0.4% 0.2% -3.1% 0.7% 0.5% 10.0%
Earnings BIT 69.26
18.16
45.66
-2.31
59.48
50.63
78.39
75.39
70.87
71.00
77.89
growth rate -73.8% 151.4% -100.0% 100.0% -14.9% 54.8% -3.8% -6.0% 0.2% 9.7%
Avg.PE 15.70
54.64
25.19
1,000.00
19.80
33.22
44.22
36.08
79.88
31.03
49.51
growth rate 248.0% -53.9% 3,869.8% -98.0% 67.8% 33.1% -18.4% 121.4% -61.2% 59.6%
ROA 4.88
1.28
3.12
0.08
4.01
3.30
2.94
2.76
1.20
4.13
3.00
growth rate -73.8% 143.8% -97.4% 4,912.5% -17.7% -10.9% -6.1% -56.5% 244.2% -27.4%
ROE 8.60
2.19
5.22
0.13
6.86
5.92
5.42
5.23
2.52
9.16
6.32
growth rate -74.5% 138.4% -97.5% 5,176.9% -13.7% -8.5% -3.5% -51.8% 263.5% -31.0%
ROIC 7.02
2.26
4.55
0.68
5.98
5.02
4.43
4.12
2.72
8.25
5.14
growth rate -67.8% 101.3% -85.1% 779.4% -16.1% -11.8% -7.0% -34.0% 203.3% -37.7%
Cur. Ratio 3.92
4.12
1.95
2.72
2.83
3.34
3.28
3.40
2.90
2.38
2.33
growth rate 5.1% -52.7% 39.5% 4.0% 18.0% -1.8% 3.7% -14.7% -17.9% -2.1%
Quick Ratio 1.44
1.72
0.88
1.23
1.33
1.79
1.69
1.74
1.54
1.33
1.24
growth rate 19.4% -48.8% 39.8% 8.1% 34.6% -5.6% 3.0% -11.5% -13.6% -6.8%
Leverage 1.75
1.66
1.68
1.63
1.79
1.80
1.89
1.90
2.29
2.15
2.07
growth rate -5.1% 1.2% -3.0% 9.8% 0.6% 5.0% 0.5% 20.5% -6.1% -3.7%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 96.50
126.20
145.40
145.92
153.95
157.43
129.87
133.86
148.24
167.04
181.55
growth rate 30.8% 15.2% 0.4% 5.5% 2.3% -17.5% 3.1% 10.7% 12.7% 8.7%
Acct.Payable 58.77
59.84
62.99
23.75
34.72
41.65
42.04
53.50
growth rate 1.8% 5.3% -62.3% 46.2% 20.0% 1.0% 27.2%
Cur.Assets 293.00
325.60
350.20
356.72
348.89
372.13
381.15
359.80
330.51
356.78
374.35
growth rate 11.1% 7.6% 1.9% -2.2% 6.7% 2.4% -5.6% -8.1% 8.0% 4.9%
Total Assets 931.70
958.40
985.80
935.59
1,078.85
1,090.51
1,098.19
1,101.70
1,328.98
1,357.96
1,369.14
growth rate 2.9% 2.9% -5.1% 15.3% 1.1% 0.7% 0.3% 20.6% 2.2% 0.8%
Cash 11.80
10.10
12.40
26.05
23.72
54.44
66.33
72.50
27.43
32.62
17.51
growth rate -14.4% 22.8% 110.1% -8.9% 129.5% 21.8% 9.3% -62.2% 18.9% -46.3%
Inventory 160.00
164.30
172.80
168.44
156.23
143.21
148.15
133.36
135.87
141.44
154.60
growth rate 2.7% 5.2% -2.5% -7.3% -8.3% 3.5% -10.0% 1.9% 4.1% 9.3%
Cur.Liabilities 74.90
79.10
179.90
131.18
125.21
111.27
115.96
119.72
113.95
150.00
160.94
growth rate 5.6% 127.4% -27.1% -4.6% -11.1% 4.2% 3.2% -4.8% 31.6% 7.3%
Liabilities 391.40
381.90
399.20
362.52
471.85
484.19
516.90
516.63
748.41
726.53
706.87
growth rate -2.4% 4.5% -9.2% 30.2% 2.6% 6.8% -0.1% 44.9% -2.9% -2.7%
LT Debt 182.70
182.20
85.20
88.95
160.80
214.44
240.20
269.47
488.29
471.74
438.56
growth rate -0.3% -53.2% 4.4% 80.8% 33.4% 12.0% 12.2% 81.2% -3.4% -7.0%
Equity 540.20
576.50
586.60
573.07
607.00
606.32
581.30
585.07
580.58
631.43
662.27
growth rate 6.7% 1.8% -2.3% 5.9% -0.1% -4.1% 0.7% -0.8% 8.8% 4.9%
Common Shares 29.00
29.00
29.00
29.00
29.00
28.00
28.00
28.00
28.00
28.00
29.00
growth rate 0.0% 0.0% 0.0% 0.0% -3.5% 0.0% 0.0% 0.0% 0.0% 3.6%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 35.90
21.40
14.70
17.55
21.53
18.45
15.41
15.01
14.75
12.84
16.51
growth rate -40.4% -31.3% 19.4% 22.7% -14.3% -16.5% -2.6% -1.7% -13.0% 28.5%
Cash Dividends 0.00
0.00
0.00
0.00
12.86
16.70
21.96
22.11
22.21
22.31
22.44
growth rate 29.8% 31.5% 0.7% 0.5% 0.4% 0.6%
Cash From OA 61.10
25.00
38.20
102.99
95.20
80.95
65.18
50.92
39.88
65.57
74.70
growth rate -59.1% 52.8% 169.6% -7.6% -15.0% -19.5% -21.9% -21.7% 64.4% 13.9%
FCF per Share 0.86
0.12
0.81
2.90
2.57
2.42
1.78
1.79
0.72
1.54
1.93
growth rate -86.1% 575.0% 258.0% -11.4% -5.8% -26.5% 0.6% -59.8% 113.9% 25.3%
Sale Purchase of Stock -8.90
6.24
-33.29
-16.86
0.83
growth rate 100.0% -100.0% 0.0% 100.0%
FCF 25.00
4.00
24.00
85.00
74.00
63.00
50.00
33.00
23.00
53.00
58.00
growth rate -84.0% 500.0% 254.2% -12.9% -14.9% -20.6% -34.0% -30.3% 130.4% 9.4%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 742.20
694.70
713.70
725.08
767.14
762.70
740.06
719.17
763.52
796.39
859.63
growth rate -6.4% 2.7% 1.6% 5.8% -0.6% -3.0% -2.8% 6.2% 4.3% 7.9%
Op.Income 75.30
28.30
57.10
0.75
40.48
35.68
78.39
75.39
70.87
71.00
77.89
growth rate -62.4% 101.8% -98.7% 5,283.1% -11.9% 119.7% -3.8% -6.0% 0.2% 9.7%
IBT 62.00
18.20
45.70
-2.31
59.48
50.63
46.68
45.14
19.38
28.73
50.65
growth rate -70.7% 151.1% -100.0% 100.0% -14.9% -7.8% -3.3% -57.1% 48.3% 76.3%
Net Income 40.00
12.10
30.30
0.75
40.48
35.68
32.19
30.50
14.66
55.49
40.85
growth rate -69.8% 150.4% -97.5% 5,283.1% -11.9% -9.8% -5.3% -51.9% 278.4% -26.4%
EPS 1.37
0.42
1.05
0.03
1.41
1.28
1.16
1.09
0.52
1.97
1.41
growth rate -69.3% 150.0% -97.1% 4,600.0% -9.2% -9.4% -6.0% -52.3% 278.9% -28.4%
Gross Profit 382.40
337.30
365.40
374.93
405.84
412.42
409.67
389.72
415.94
433.94
469.11
growth rate -11.8% 8.3% 2.6% 8.2% 1.6% -0.7% -4.9% 6.7% 4.3% 8.1%
R&D 33.10
31.80
29.70
28.65
28.21
25.83
27.78
27.44
32.25
32.31
37.98
growth rate -3.9% -6.6% -3.5% -1.5% -8.5% 7.5% -1.2% 17.6% 0.2% 17.6%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 16.68
16.81
27.12
19.22
21.30
growth rate 0.8% 61.4% -29.1% 10.8%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 161.69
161.00
181.55
172.20
179.04
growth rate -0.4% 12.8% -5.2% 4.0%
Acct.Payable 52.12
48.23
53.50
54.49
51.14
growth rate -7.5% 10.9% 1.9% -6.2%
Cur.Assets 347.40
363.46
374.35
390.71
397.28
growth rate 4.6% 3.0% 4.4% 1.7%
Total Assets 1,363.73
1,362.98
1,369.14
1,760.84
1,759.40
growth rate -0.1% 0.5% 28.6% -0.1%
Cash 23.40
29.69
17.51
23.41
22.55
growth rate 26.9% -41.0% 33.7% -3.7%
Inventory 143.41
153.62
154.60
171.09
172.80
growth rate 7.1% 0.6% 10.7% 1.0%
Cur.Liabilities 176.67
164.89
160.94
151.27
155.80
growth rate -6.7% -2.4% -6.0% 3.0%
Liabilities 715.54
710.32
706.87
1,067.78
1,062.39
growth rate -0.7% -0.5% 51.1% -0.5%
LT Debt 432.24
442.90
438.56
803.31
795.91
growth rate 2.5% -1.0% 83.2% -0.9%
Equity 648.19
652.66
662.27
693.06
697.01
growth rate 0.7% 1.5% 4.7% 0.6%
Common Shares 0.31
0.31
0.31
0.31
0.31
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 3.51
4.46
4.76
4.02
4.98
growth rate 27.1% 6.6% -15.4% 23.9%
Cash Dividends 5.61
5.62
5.62
5.63
5.64
growth rate 0.3% 0.1% 0.0% 0.3%
Cash From OA 20.63
4.35
24.70
-3.92
21.58
growth rate -78.9% 467.8% -100.0% 100.0%
Sale Purchase of Stock
growth rate
FCF 17.12
-0.11
19.95
-7.94
16.59
growth rate -100.0% 100.0% -100.0% 100.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 212.82
202.31
242.44
218.38
238.26
growth rate -4.9% 19.8% -9.9% 9.1%
Op.Income 16.68
16.81
27.12
19.22
21.30
growth rate 0.8% 61.4% -29.1% 10.8%
IBT 11.59
6.31
20.29
-1.96
6.50
growth rate -45.6% 221.7% -100.0% 100.0%
Net Income 8.72
5.83
15.65
1.02
5.70
growth rate -33.2% 168.7% -93.5% 457.8%
EPS
growth rate
Gross Profit 116.27
110.63
132.66
122.10
131.69
growth rate -4.9% 19.9% -8.0% 7.9%
R&D 9.99
9.91
10.37
10.58
11.81
growth rate -0.8% 4.7% 2.0% 11.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (38.86)

YOY Growth Grade:

F (6.71)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 76.39 91.94 28.35
EPS / Growth 0.2% 1.08 13.6%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 3.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 0.2% 1.6% 1.6%
Future PE 0.42 15.77 15.77
Future EPS 1.10 1.26 1.26
Value Price
MOS %
0.11
-99.9%
4.93
-95.0%
4.93
-95.0%
MOS Price 0.06 2.46 2.46
IRT 83.99 56.51 56.51

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.